Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Change in Account Payables (2024 - 2025)

Carlsmed (CARL) has disclosed Change in Account Payables for 2 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 406.54% year-over-year to $1.6 million, compared with a TTM value of $1.7 million through Dec 2025, changed N/A, and an annual FY2025 reading of $2.3 million, up 682.15% over the prior year.
  • Change in Account Payables was $1.6 million for Q4 2025 at Carlsmed, up from $682000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.6 million in Q4 2025 and bottomed at -$535000.0 in Q4 2024.